Risk Factors for Cryptococcal Meningitis Recurrence in Human Immunodeficiency Virus (HIV)-Infected Patients in a Large Chinese Acquired Immune Deficiency Syndrome (AIDS) Treatment Center

15 December 2021 : Clinical Research

Yue Zhou^1AEF, Feng Li^1BCD, Rui Li^1BCD, Yuan Peng^1CD, Mei He^1CD, Fengjun Sun^2ADEF*, Ming Yang^12AEFG

DOI: 10.12659/MSM.933688

Med Sci Monit 2021; 27:e933688

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Table 4 Antifungal drug susceptibility results (mg/L).

Antifungal agent	MIC90	MIC50
Amphotericin B	2	0.25
Itraconazole	0.5	≤0.125
Voriconazole	1	≤0.125
Fluconazole	8	2
5-fluorocytosine	4	0.5
MIC – minimum inhibitory concentration.

Back to the Article